Observational studyBreast cancer (Tokyo, Japan)2024

A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer.

Kumiko Kida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.